Role of intracoronary stent implantation
ultrasound
James W. Choi, MD, Gil M. Vardi, MD, Sheridan and Charles J. Davidson, MD Cbkugo, IU
Background unknown inflation
is used
improved
with
during
defined
with
inflations performed.
ICUS
were
tial acute 24
7.6
f 2.2
(16%) mm2
(P < .OOOl). than The and
or equol
had
a symmetry
to 9.2 to ICUS
in optimizing ICUS
Even
acute
guidance (Am
gain,
is associated Heart
stents
reference
vessel event repeat
with
Forty-six
requiring
). Similarly,
were
diameter
were
rate
at 6 months
or larger
used
balloon
stent
in 33 was
in 40
after
which
reference
lumen
balloons
and
subsequent
stent
found
stent
from
in 95
If inad-
reevaluation (23%)
had
(99%)
ini-
struts
increased balloons
vessel
result
area.
to 68%
larger
obtained
of 8 target
35
atm
index
ICUS
unapposed
area
33%
whereas was
stents,
to have
minimum
improved
consisted
An optimal
Of these
patients,
Follow-up
which
stenosis),
of the
were
were (212
20.80
stents
are
15 1 stents
High-pressure
evaluated.
inflations,
patients.
9.3%,
residual
apposition
performed
in whom
estimation.
inflations.
(30%)
techniques inflation.
were
gain
additional
complete
dilations
acute
additional
area.
(~10%
dimensions
pressures
required lumen
high-pressure and
low
and
balloon
patients
it is balloon
from
of total
stents
greater patients.
revascularizations
intervention.
poststent
symmetry,
20.80,
higher
In patients
(P c .OOOl
cardiac
when
with
higher-pressure
reference requiring
(46%)
ratio
lumen
deployment
RN,
However,
high-pressure
if stent
1: 1 by visual
completion
and
initial
high-pressure
consecutive
sized
M. Goodreau,
outcomes.
after
to determine with
RN, Lynne
clinical
guidance
achieved
on 96
angiographic
symmetry
~0.80.
collected
symmetry,
dilations
of the
mm2
until
apposition,
ratio
ICUS,
adverse
Conclusions
were
angiographically
further
~80%
f 2.4
initial
closure
data
to improve
clinical was
high-pressure
A. Parker,
shown
result
were
continued
been
of this study
angiographic
balloons
Sixty-nine
were
major
1 abrupt
found,
the purpose
Prospective
Stent
that
After
overall
follow-up.
Thus
were
performed.
gains
additional
an optimal
of the stent,
were
has
p rovides
despite
as full apposition results
inflation
(ICUS)
placement.
high-pressure
was
ICUS
and
and
balloon
imaging
equate
stent imaging
MD, Michelle
balloon
ultrasound
and Results Stents
in all cases) was
high-pressure
introcoronary ICUS
Methods deployed. ICUS
Poststent
whether
N. Meyers,
after
apposition
rates
for
target
balloon
inflation
of introcoronary vessel
achieves stents
revascularization
an optimal
angiographic
in approximately and
maior
50% adverse
result, of patients.
cardiac
events
ICUS
assists
Moreover, at 6-month
J 2000;139:643-8.)
The use of stents as initial interventional treatment of coronary artery disease has been shown to be clinically superior to that of balloon percutaneous transluminal coronary angioplasty and to provide long-term benefits. l-6 Stents have been used successfully in de novo coronary lesions,@ chronic total occlusions,9 and saphenous vein bypass graft stenoses.rO Despite the superior results of stents, suboptimal deployment may lead to subacute thrombosis*tvla and/or restenosis caused by neointimal hyperplasia. Moreover, reductions in restenosis rates
From Northwestern Univen~ty Medical School. Presented in port at the Tronscatheter Cardiovascular Therapeutics Annual Sympo sium, Ott 1998, Washington, DC. Submitted March 30, 1999; accepted September 25, 1999. Reprint requests: Charles J. Davidson, MD, Northwestern University Medical School, 25 I E Huron #8-526, Chicago, It 606 1 I. E-mail:
[email protected] Copyright 8 2000 by Mosby, Inc. 0002.8703/2000/$12.00 +0 4/l/103540 doi: 10.1067/mhi.2000.103540
have been demonstrated by increasing acute gains and decreasing elastic recoil of the treated vessel walI. l3 Previous work with intracoronary ultrasound (ICUS) has proven that visual or quantitative angiographic measurements of vessel dimensions for stent expansion and deployment appear to be inadequate.1422 Repeat inflations with larger balloons or higher-pressure inRations are often necessary to improve stent apposition and optimize luminal cross-sectional area (CSA).14,22-26 Furthermote, high-pressure dilation under ICUS guidance may improve luminal CSA and reduce stent restenosis. 11 Currently, high-pressure balloon dilation with the use of a balloon with a diameter equal to or slightly larger than the angio graphic reference segment is used routinely. Despite this accepted practice, it is unknown whether stent apposition, symmetry, and optimal expansion are routinely achieved after angiogtaphically guided high-pressure balloon dilation. It has been suggested that ICUS is not routinely necessary after high-pressure diIation.26 The purpose of this study was to determine if stent deployment
American
644
Choi
Table Age
(~1
Men Single stent 2 Stents 13 Stents No. of stents per patient Vessel distribution LAD RCA LCX SVG QCA reference diameter 2.00-2.49 mm 2X-2.99 mm 3.00-3.49 mm 3.50-3.99 mm 4.00449 mm 4.50-4.99 mm Stent size 3.0 mm 3.5 mm 4.0 mm 4.5 mm 5.0 mm Balloon diometer (mm) Inflation pressure (oh-n) No. of inflotions per stent
Heart Journal April 2ooO
et 01
64+ 10 72 (75%) 55 (75%) 27 (28%) 14(15%) 1.57 * 0.74 62 40 18 31
(41%) (26%) (12%) (21%)
8 46 63 18 10 3
(5%) (31%) (43%) (12%) (7%) (2%)
61 68 27 1 5 3.6 15.5f 3.2
(38%) (42%) (14%) (1%) (3%) f 0.4 1.6 zk 2.0
Data are mean f SD; number (%) of pattenk, stenk, vessels treated, or stent sizes. lAD, Left anterior descending artery; RCA. right coronary artery; LCX, left circumflex coronary artery; SVG, saphenous vein bypass graft.
techniques are improved by ICUS imaging despite an optimal angiographic result achieved with high-pressure balloon dilation.
Methods The study population consistedof 15 1 consecutive PalmazSchatz oohnson &Johnson Interventional Systems, Warren, NJ) stent implantationsin % patients. Lesionsin both native coronary atteries (n = 120) and saphenous vein bypass grafts (n = 3 1) wm ineluded. At the time of this study, aspirin and coumarin were routIne.ly used as the poststent anticoagukition regimen. Stent implantation procedure After balloon predilation, the PaImaz-Schatz stems were deployed with the stent delivery system previously described.* With the use of noncompliant balloons that were angiographicaIly sized 1: 1 to equal the reference segment lumen diameter, high-pressure inflations were performed to 112 atm (mean pnzssure of 14.9 f 1.6 atm) and until angiographic completion defined as
II. Index
ICUS
findings
of oil 96 patients
Reference lumen maximum diameter (mm) Reference lumen minimum diameter (mm) Reference lumen area (mmz) Stent CSA (mm2) Acute gain: stent/reference lumen area (%) No. of unapposed struts Symmetry index Balloon/reference lumen diameter
3.75 f 3.17 f 9.95 f 8.36 + 89.5 f 0.89 f 0.83 + 1.15f0.18
0.71 0.60 3.77 2.45 25 1.60 0.05
Dato are mean f SD.
distal to the stent and withdrawn with an automatic pullback device at 0.5 mm/s through the stent and proximal vessel. Images were simultaneously recorded on half-inch s-VHS videotape. During the procedure, the CSA of the stent was planimetered from the ultrasound images while minimum and maximum diameters were determined.” lf the initial ICUS image demonstrated optimal stent deployment, the procedure was terminated. If incomplete stent expansion, unapposed struts, or asymmetric expansion was noted on the ultrasound image, further balloon inflations were performed with either higher pressures or larger balloons. BaIIoons were upsized to equal the vessel diameter of the distal reference segment. If the balloon was already equal to the distal reference segment diameter, further dilations were performed at higher pressufes. ICUS and balloon inflations were repeated until complete apposition and symmetric stent expansion was achieved or no further improvement could be obtained. Definitions by ICUS Optimal stent deployment was determined by 3 ICUS criteria: (1) fuII apposition: complete expansion of the stent with no free space between the stent struts and the intimal surface, (2) symmetry: uniform expansion of the stent defined as the minimum-to-maximum lumen diameter ratio 20.80, (3) acute gain: optimization of the intrastent lumen CSA defined as an intrastent CSA-to-reference artery lumen CSA ratio L0.80.2z After the procedure, the ICUS images were reanalyzed offIine with the use of a computerized tracking software program (Tapemeasure, Indec, Inc, Mountainview, Calif) that calculated the CSA and measured the minimum and maximum diameters of various sites. The lumen area, defined as the blood-to-intima interface, was manually traced at 4 various locations: distal reference, distal stent, proximal stent, and proximal reference. The distal and proximal reference segments were measured at the maximum lumen CSA within 10 mm distal and proximal to the stent. Of the 2 measurements, the most normal-appearing image was used as the reference site. The distal stent dimensions were measured at the minimaI stent area between the distal articulation point and the mid-point of the stent, including both articulation points. Similarly, the proximal stent was measured at the minimal stent area between the mid-point of the stent and the proximal articulation, including both articulation points. The smaller of the intrastent CSA measurements was used in the analysis. The index image was defined as the fimt ICUS image obtained after angiographic success was achieved. The final ICUS image was defined as the image obtained at the completion of aII additional interventions.
American Heart Journal Volume 139. Number 4
Choi
Table III. Index balloon
and vessel
reference
measurements
in stents with and those Additional
-
without
intervention (n = 69)
intervention
No additional intervention (n = 82)
9.61 k3.4 3.52 f0.34 3.18 kO.48 1.12f0.15 3.68 f0.69 1.14f0.18 2.1 f0.9 14.2+ 1.9
Reference lumen area Balloon size (mm) Reference lumen diameter by QCA (mm) Balloon/reference by QCA Reference lumen diameter by ICUS (mm] Balloon/reference by ICUS No. of balloon inflations Maximum initial stent inflation pressures (atm)
additional
et 01 645
10.23 f4.1 3.59f0.45 3.26kO.55 1.12f0.14 3.82kO.73 1.15f0.17 2.4+ 1.4 14.2 +2.0
P value .32 .27 .35 .85 .23 .lO .15 .89
Data are meon + SD
Table
IV.
index
stent measurements
in stents with and those
withoirt
Additional
Stent CSA (mm*) Maximum stent diameter (mm) Minimum stent diameter (mm) Symmetry index Incomplete apposition No. of unapposed struts Acute gain (%)
Angiographic
measurements
Quantitative angiography also was performed off-line with a computerized semiautomated edge detection algorithm system (Artrek, ImageComm Inc, Santa Clara, Calif). The guide catheter was used for calibration. Follow-up
Patients were contacted by telephone or questioned during their office visit at 6 months. Major cardiac events defined as target vessel revascularization, coronary artery bypass surgery, cardiac death, and history of myocardial infarction defined as creatine kinase-MEi >3 times normal with electrocardiographic changes were recorded. Statistics
The data are expressed as mean value f SD. Continuous variables were compared by paired t test. Correlations were tested by &i-square test. Differences were considered significant at the level of P < .05.
Results Ninety-six consecutive patients received 15 1 PahnazSchatz stents with subsequent ICUS imaging. The study population consisted of 72 (75%) men with a mean age of 64 f 10 years. In all patients, stents were successfully deployed at the stenosis site. No ICUS-related complications, including prolonged or severe spasm,
qdditionol intervention (n = 69) 7.64k2.25 3.35 f0.47 2.76kO.45 0.82 f0.05 67%(46) 1.90 f
1.93
85+26
intervention No additional intervention (n = 82)
P value
8.97+ 2.47 3.59f0.50 3.03 kO.41 0.84f0.05 S%(5) 0.05 + 0.22 94f24
~0008 co3 c.0002 co5 <.OOOl <.OOOl c.02
were noted. Vessel size and distribution as weII as the stent characteristics are listed in Table I. ICUS findings at angiographic completion After angiographic completion, the index ICUS was analyzed as shown in Table II. The mean lumen diameter of the reference segment as measured by qualitative coronary angioplasty (QCA) was 3.22 f 0.52 mm vs 3.75 f 0.71 mm by KU.5 (P c .OOOl).In 82 (54%) stems, the index ICUS resuk met criteria for an optimal result and the procedure was terminated. In 69 (46%) stents, further balloon inllations were needed to achieve the criteria of optimal stent deployment (Table III). When comparing the 2 groups (Table IV), the group requiring additional intervention had (1) smaller CSA (7.64 f 2.25 mm2 vs 8.97 f 2.47 mm2, P c .OOOS),(2) smaller maximum and minimum diameters (maximum diameter
Index
3.35*0.47mmvs3.59*0.50mm,P<.003,lIlinimum diameter2.76~0.45mmvs3.03~0.41 mm,P<.OOO2), (3) increased number of unapposed struts (1.90 f 1.93 vs 0.05 f 0.22, P c .OOOl),and (4) less acute gain @tent area/reference lumen area 84.5% f 25.9% vs 93.7% f 23.6%, PC .02). intervention group In the 69 stents that required additionai intervention, larger balloons were used in 33 stems, of which 11 also
Additional
646 Choi
Amerlcon Heart Journal April 2030
et 01
$#&&i@&$w
additifm~l~in~rventian
(69
stents)’
I Index Complete strut apposition Symmetry ratio 20.80 Acute gain >O.Sg Stent CSA (mm2) No. of unopposed struts Maximum diameter (mm) Minimum diameter (mm) Acute gain (%) Symmetry index
ICUS
Final
23 (33%) 45 (65%) 34 (49%) 7.64 k 2.25 1.91 f 1.93 3.35 zk 0.47 2.76 f 0.45 85+26 0.82 + 0.05
ICUS
47 (68%) 54 (78%) 52 (75%) 9.25 f 2.42 0.26 f 0.53 3.67 f 0.5 1 3.05 + 0.46 102f28 0.83 f 0.07
P value coo0 1 c.06 coo0 1 <.ooo 1 <.OOOl c.000 1 <.OOOl <.ooo 1 Nat significant
Data ore meon It SD or n (%).
::$f!$$$@$(tid
f?eini:tkbirements
.
of addi@onal
intervention
group Additional
Stent CSA ( mm2) Maximum stent diameter (mm) Minimum stent diameter (mm) Symmetry index No. of unappased struts Acute gain (%)
vs index. stent measurements intervention (n * 69)
9.25 + 3.67 f 3.05 f 0.83 f 0.26 zt 102f28
2.42 0.5 1 0.46 0.07 0.53
of qo-additional-interntion
group
No additional intervention (n = 82)
P value
8.97 f 2.47 3.59 f 0.50 3.03 f 0.41 0.84 310.05 0.05 f 0.22 94f24
.48 .31 .72 .48 e.003 c.04
Dab are mean f SD.
required higher innation pressures. ‘IXrty-six stems did not require upsizing of balloons; however, of these, 29 required additional intlations with higher pressures. Balloon diameters were upsized by 0.5 mm in 20 (29%) and by 21 .Omm in 7 (10%) of the 69 stems requiring additional interventions. Of the stems requiting additional interventions with larger balloons, the mean increase in balloon size was 0.45 f 0.21 mm. Likewise, in the stems requiring addltional inflations with the same size balloon and an increase in balloon pressure, the mean increase in maximum ballmn inflation pressure was 1.9 f 1.7 attn. Furthermore, of the 69 stems that required additional interventions, 46 had incomplete apposition of the stent, 24 had a symmetry ratio <0.80, and 35 had acute gain
follow-up
One patient had abrupt stent closure after the procedure that required emergency intervention.. Within 6
month follow-up there were 2 cardiac deaths, 1 ventricular septal rupture, and 8 cases of target vessel revascularization, which consisted of 2 coronary artery bypass surgeries and 6 repeat interventions. No myocardial infarctions were noted. One patient was lost to followup. Therefore the total overall major adverse cardiac event rate at 6 months was 11 (11%) of 96.
Discussion Our study demonstrates that despite optimal angiographic results after poststent high-pressure balloon inflation, inadequate stent deployment is frequently noted with the use of ICUS criteria. This study further demonstrates that ICUS can be used to improve the acute gain and stent apposition during stent deployment. Several studies have shown that improvements in acute luminal diameter after the procedure translate to clinical reduction of restenosis.36 Previous work by Colombo et al** and others have demonstrated that repeat high-pressure dilation was necessary to achieve optimal stent expansion as guided by ICUS after initial stent deployment with nominal balloon pressures. On the basis of ICUS imaging, it was shown that with highpressure balloon inflations and selection of larger balloon size (equal to or larger than the reference segment lumen diameter), stent expansion, strut apposition, and symmetry can be improved.r*~**-26 High-pressure dilation thus has become routine during stent deployment.
American Heart Journal Volume 139, Number 4
In our series of 151 stents, only 54% had adequate stem expansion after initial high-pressure dilation as measured by ICUS imaging. All, however, had satisfactory angiographic results as determined by the operator before ICUS imaging. The number of suboptimal results after high-pressure dilation as noted by ICUS, despite optimal angiographlc appearance, was lower than in previous
[email protected] difference probably is a result of the strategy of using initial high-pressure inflation in all cases. Despite this difference, stents still frequently required additional inflations. Even after initial high-pressure inflations, only 67% of the stents had complete strut apposition. This increased to 87% after repeat inflations (P c .OOl), whereas the number of unapposed struts decreased from 1.9 to 0.3 struts per stent (P < .OOOl).Furthermore, in the 69 stents that required additional intervention, only 33% of the stents had complete strut apposition after index intravascular ultrasound images. After repeat interventions, complete strut apposition increased to 68% (P < .OOO1). Because the presence of unapposed struts has been associated with subacute thrombosis,29 the improvement in stent apposition achieved with ICUS guidance is signikant. Maximizing luminal and intrastent CSA has been shown to lower restenosis rates8s so Furthermore, ICUS assistance has been used in improving lntrastent CSA.it One potential explanation for the improved results after ICUS is that the lumen size was initially underestimated by anglography. In our series, the mean lumen diameter by QCA was 3.22 f 0.52 mm, whereas the mean maximum lumen diameter by ICUS was 3.75 f 0.71 mm (P < .OOOl).As a result, balloon size was increased ln 48% of the stems that underwent additional dilations after ICUS. Moreover, a statistically significant increase in balloon size of 0.22 f 0.28 mm was noted. Therefore the more precise lumen size with ICUS appears to aid in maximizing stent CSA. Table III demonstrates that with the use of anglographic criteria, the characteristics of the additional intervention group were similar to those of the noadditional-intervention group. However, Table IV clearly shows that in the additional intervention group, ICUS measurements revealed significant underexpansion, nonapposition, and asymmetry compared with the noadditional-intervention group. Thus ICUS was able to identify abnormalities that were improved and documented on the final ICUS images (Table V). limitations
Although this study was prospective in its design, the use of ICUS was not randomized, and the operator was not blinded to the ICUS findings. However, it should be noted that data were analyzed after the procedure by an independent observer. Postprocedure antlcoagulation with coumarin may influence our major adverse
Choi
et al 647
cardiac event rate to be higher than would be expected with the currently accepted use of ticlopidine. Nonetheless, the use of coumarin should not have altered the measurements of stent deployment mechanics. Conclusions
Poststent high-pressure balloon dilation has improved stent deployment. Given the era of stenting with highpressure innations, the utility of ICUS in stent deployment has been questioned. However, as these data demonstrate, there is still a large percentage of stems that do not achieve optimal stent deployment as evaluated by ICUS, even after routine high-pressure dilation had produced an acceptable angiographic result. Therefore, despite high-pressure balloon dilation with an optimal angiographlc result, intravascular ultrasound lmaglng can provide incremental clinical information when attempting to optimize intracoronary stent placement.
References 1. Sigwart
U, Puel J, Mirkovitch
occlusion and restenosis Med 1987;3 16:701-6.
V, et al. Intravascular
after transluminol
stems to prevent
ongioplasty.
N Engl J
2. Schatz RA, Bairn DS, Leon M, et al. Clinical experience Palmoz-Schotz coronary stent. Circulation 1991;83:148-61. 3. Fischmon
with the
DL, Leon MB, Bairn DS, et 01. A randomized
son of coronary-stent treatment of coronary
compari-
placement and balloon angioplasty in the artery disease. N Engl J Med 1994:33 1;
496-501. 4. Mocayo
C, Serruys
PW, Ruygrok
P, et al, Continued
coronary stenting versus bolloon ongioplasty: l-year of Benestent Triol. J Am Coll Cardiol 1996;27:2556 5. Sovoge
MP, Fischman
DL, Schatz
benefit
ftA, et al. long-term
ond clinical outcome after implantation stent in the native coronary circulation.
of
clinical follow-up 1. angiographic
of a balloonexpandable J Am Coll Cardiol 1994;
241207-12. 6. Kimuro T, Yokoi H, Nokagawa implantation 3345616. 7. Serruys
of metallic
PW, De Joegere
lwnexpandablestent
or stenting.
F, et 01. A comparison
with balloon angioplasty
of bal-
restenosis
1992;86:
after coronary
atherectomy
1827-35. stent inserJ Am Coll
1995;26:713-9.
10. Savage
MP, Douglas
JS, Fischman
DL, et al. Stent placement
pared with balloon ongioplasty for obstructed grafts. N Engl J Med 1997;337:740-7. 1 1. Hoyose
M, Oshima
coronary
and minimum stent area
(CRUISE trial) [abstract].
corn
bypass
A, Zidor JP, et al. Relation between
sel revosculorization sound
1996;
in patienk
9. Goldberg St, Colombo A, Maiello 1, et 01. lntracoronary tion after balloon ongioplasty of chronic total occlusions. Cardiol
after
N Engl J Med 1994;33 1:489-95. JP, et al. The importance of acute
in determining
Circulation
followup
stenk. N Engl J Med
P, Kiemenei]
implantation
with coronary ortery disease. 8. Kuntz RE, Safion RD, Corroua luminal diometer
Y, et al. Threeyear
coronaryartery
target ves-
by intravascular
J Am Coil Cordiol
1993;3
ultra1 [suppl
A]:3867A. 12. Corroua
JP, Kuntz RE, Levine Ml, et al. Angiographic
come of introcoronary large single-center 13. Houde
stenttng: immediate
experience.
and clinical out-
and longterm
J Am Coll Cardiol
M, Erbel R, lssa H, et al. Quontitotive
results from a
1992;20:328-37. analysis
of elastic
648
Choi
Amerlcon Heart Journal April 2000
et al
recoil ofter balloon
ongioplosty
of balloonexpondoble 1993;2
implantation
Coll Cardiol 23.
S, Colombo
observations
A, Gaglione
during
A, et al. Introcoronary
stent implantation.
Circulation
ultra-
Schotz
introcoronary
sound
balloon
16. Laskey WK, sound
catheter. Brady
assessment
HeortJ
catheter-based ultrasound. 18. Covaye
1994;90: WG,
12526
1.
et al. intravascular
of the results of coronary
ultro-
artery
25. ultra-
stenting.
interventional
procedures
ossessed
DM, Tobbara
MR. Kopchok
of vascular
Am
by intravascular
lar ultrasound dissection
in dogs
minol stenting. 20. Tenaglio
AN,
wire-directed 2 1. Deoner
GE, et al. lntroluminal
experimentally
and for determining
ultrasound
St, Colombo
induced
the effectiveness
27.
ultrasound
after low J Am
1996;77:455-6 G, Slagboom Diagn
of stent
1. T. Percutaneous
stent implontation,
Cathet Cordiovosc
of on-line 3dimensional for guidance
guided
1995;34:
F, Jan Larrman
G, Slagboom
coronary
Palmoz-Schotz
stents after implantation
Nishimuro
RA, Edwards
imaging:
Int J Cordiol
28. Colombo
aortic
transrodial
by introvascular
1336.
T. Mode
ultrasound
of deployment
of
with the stent deliv-
study. Am Heart J 1995;
of endolu-
1992;36:
125: 12 136.
of coronary
stent
1246.
S, et al. Benefit of introcoro
30.
WD, Warnes
in vitro validation
1990;
Circulation
Uren NG,
Scwarzocher
prediction
of stent thrombosis:
[abstract].
J Am Coll Cardiol
RE, Gibson
of restenosis directional
ultro-
correlation.
S, et al. Introcoronary
accomplished
guidance.
Kuntz
CA, et al. Introvascular
and pathologic
J Am
16: 145.54.
A, Hall P, Nokomuro
out onticoagulotion
guide
Am Heart J 1993;
AA, Rees MR. Assessment A, Nokamuro
ultrasound
stent implantation.
Kiemeneij
sound
29.
Kisslo K, Kelly S, et al. Ultrasound
ultrasound.
of introvascu-
1992;69:705-7.
stent deployment.
artery
C, Gil R, et al. Usefulness
ery system: on intravascular
Ann Vosc Surg 1991;
RD. et al. Usefulness
for detecting
Am J Cardiol
AN, Cubukcu
by intravascular Goldberg
imaging
stents. J Am
129:63844.
stent deployment. RA, Lerman
coronary
of intracoronory F, Jon Lorrmon
ultrasound.
of complex
pressure
Palmaz-Schotz
Coll Cardiol DM, White
M, Ge J, et al. Intravascular
Am J Cordiol
Kiemeneii coronary
26.
AD, Kent KM, et al. Failure or success
Prati F, Di Morio deployment.
l-6.
19. Covaye
22.
Circulation
ST, Kussmaul
introvosculor
of Palmoz-Schotz
1995;26:725-30.
reconstruction
Am Heart J 1992;123:200-8.
assessment 524
with a combined
of Palmaz-
1993;125:1576.83.
17. Keren G, Pichard
.
stenting
guidance
G, Houde
Coll Cordiol 24.
t-l, Klouss V, Blosini R, et al. Ultrosound
Gorge
in the deployment 1994;24:996-1003.
and high inflotion
1994;
092026-34. 15. Mudra
nary ultrasound
stents. 1 Am Coll Cardiol
1:26-34.
14. Nakamura sound
and after introcoronory
Palmaz-Schatz
CM,
1995;9
atherectomy.
ultrasound
1: 167688.
SP, Metz
JP, et al. Introvascular
insights
ultrasound
from the POST registry
1997;29[suppl
Nobuyoshi
after conventional
stenting with-
with intravascular
A]:60A.
M, et 01. Generalized
balloon
ongioplasty,
J Am Coll Cardiol
1993;2
stenting 1: 1525.
model and